Quantity performed	7
Exception?	No exception
Die mengenmäßige Erwartung wurde aufgrund der Covid-19-Pandemie und der Übergangsrelung zur Mindestmengenerhöhung sowie der Streichung von OPS-Kodes, zum Erreichen der Mindestmengen ab 01.07.2021, nicht erreicht.

Complex operations on the pancreatic organ system

Quantity performed	25
Exception?	No exception

Minimum quantities forecast

Knee joint total endoprostheses

Overall result forecast presentation:	yes
Quantity performed reporting year:	60
Quantity forecast year:	67
Examination by state associations?	yes
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Complex operations on the pancreatic organ system

Overall result forecast presentation:	yes
Quantity performed reporting year:	25
Quantity forecast year:	32
Examination by state associations?	yes
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Complex interventions on the organ system esophagus for adults

Overall result forecast presentation:	no
Quantity performed reporting year:	7
Quantity forecast year:	1
Examination by state associations?	no
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ25	Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ28	Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction)

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
249	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
156	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
132	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children

Use of standardised forms for drug medical history

Risikomanagement-Handbuch

14.04.2022

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Risikomanagement-Handbuch

14.04.2022

SOP on good prescription practices

Risikomanagement-Handbuch

14.04.2022

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Fallbesprechungen
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)

Measures to ensure seamless drug therapy after discharge

bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
Aushändigung des Medikationsplans
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen

Special instrument-based equipment

Research & teaching

Job

FL09 - Doctoral supervision

Explanation

Betreuung von Doktoranden der Charité Universitätsmedizin Berlin Betreuung von Doktoranden der Universitätsmedizin Greifswald

FL08 - Editors of scientific journals/textbooks

Explanation

Herausgeber kma Klinik Management aktuell Herausgeber Krankenhausmanagement, Strategien, Konzepte, Methoden Herausgeber Kompendium der medizinischen Begutachtung Herausgeber Die obere Extremität-Schulter, Ellbogen, Hand Editor, The Scientific World Journal Editor, Journal of Hand Surgery Global

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

Survival of patients with recurrent malignant brain tumor (glioblastoma multiforme) treated with surgical resection and local chemotherapy using impregnated wafer in relation to a clinical predictor; the methylation of methylguanin-DNA-methyltransferase promotor (CARMUSTIN, ISRCTN 15192099)

FL06 - Participation in multi-centre phase III/IV studies

Explanation

EudraCT No.: 2013-005326-38 EudraCT No.: 2014-000303-28 EudraCT No.: 2014-001672-55 EudraCT No.: 2014-003066-24 EudraCT No.: 2017-002429-39

FL05 - Participation in multi-centre Phase I/II studies

Explanation

EudraCT No.: 2016-003927-45 EudraCT No.: 2018-000812-47 EudraCT No.: 2017-004149-26 EudraCT No.: 2016-001227-31 EudraCT No.: 2021-000613-16

FL04 - Project-related cooperation with colleges and universities

Explanation

Charité Berlin Universität Greifswald Universitätsspital Basel TU Berlin Private Universität Witten/Herdecke Medizinische Universität Innsbruck Ruhr Universität Bochum Universitätsklinikum Hamburg Eppendorf Alice-Salomon Hochschule Berlin Medizinische Hochschule Hannover

FL03 - Student training (clinical traineeship / internship year)

Explanation

Praktische und theoretische Ausbildung von Studierenden im PJ entsprechend der Vorgaben der Charité Universitätsmedizin Berlin (aktuell Modellstudiengang)

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Charité Universitätsmedizin Berlin Ernst-Moritz-Arndt-Universität Greifswald IB Hochschule Berlin TU München Hochschule der DGUV FU Berlin Universität Hamburg RWTH Aachen Eberhard-Karl-Universität Tübingen Ruprecht-Karls-Universität Heidelberg Universität in Budapest

FL02 - Lectureships / teaching posts at universities of applied sciences